Business Context and Reporting Period
Runway Growth Finance Corp. (RWAY) is an externally managed, non-diversified closed-end management investment company regulated as a Business Development Company (BDC) and treated as a Regulated Investment Company (RIC). The company focuses on providing senior secured loans to high-growth private companies in technology, healthcare, business services, and financial services. This filing covers the fiscal year ended December 31, 2024.
On January 30, 2025, the company's investment adviser, Runway Growth Capital LLC (RGC), was acquired by affiliates of BC Partners Advisors L.P. and Mount Logan Capital Inc. (the "BCP Transaction"). The company's stockholders approved a Third Amended and Restated Advisory Agreement effective upon the closing of this transaction.
Key Financial Metrics (Year Ended December 31, 2024)
| Metric | Value |
|---|---|
| Total Investment Income | $144.6 million |
| Net Investment Income | $63.8 million ($1.64 per share) |
| Net Increase in Net Assets from Operations | $73.6 million ($1.89 per share) |
| Total Portfolio Investments (Fair Value) | $1.077 billion |
| Net Assets | $514.9 million |
| Net Asset Value (NAV) per Share | $13.79 |
| Debt Outstanding | $558.3 million |
| Asset Coverage Ratio | 192% |
| Dollar-Weighted Annualized Yield (Debt Portfolio) | 14.9% |
| Distributions Declared | $69.9 million ($1.79 per share) |
Material Changes vs. Prior Period
- Net Investment Income: Decreased to $63.8 million in 2024 from $78.3 million in 2023. This decline was primarily due to decreased investment income resulting from a lower average outstanding principal on interest-earning debt investments and declining interest rates, partially offset by decreased performance-based incentive fees and management fees.
- Net Increase in Net Assets: Increased to $73.6 million in 2024 from $44.3 million in 2023. This improvement was driven by a significant increase in net realized and unrealized gains on investments, which offset the decrease in net investment income.
- Portfolio Composition: The debt investment portfolio fair value decreased slightly to $970.2 million from $978.5 million in 2023. The equity investment portfolio fair value increased to $106.6 million from $46.5 million in 2023, largely due to increases in the fair value of preferred stock investments in Gynesonics, Inc. and CareCloud, Inc.
- Asset Quality: As of December 31, 2024, two senior secured term loans (Mingle Healthcare Solutions, Inc. and JobGet Holdings, Inc.) were placed on non-accrual status, representing 0.5% of the total investment portfolio. In 2023, there were no loans on non-accrual status.
Guidance, Outlook, and Risks
Outlook and Strategy: Management expects the BCP Transaction to position the company to expand offerings to target companies and sponsors, with global loan originations in the range of $30-$150 million. The combination aims to enhance capabilities through structured equity preferred investments, asset-based lending, and equipment leasing.
Share Repurchases: The company has an active share repurchase program (Third Repurchase Program) approved in July 2024, authorizing up to $15.0 million. As of December 31, 2024, $12.5 million had been utilized.
Risks and Contingencies:
- Interest Rate Risk: The company is exposed to interest rate fluctuations. A hypothetical 200 basis point increase in interest rates on variable-rate debt investments could increase investment income by up to $17.2 million annually, while a decrease could reduce it by $11.2 million.
- Portfolio Concentration: The five largest debt investments represented 28.8% of the total fair value of debt investments as of December 31, 2024.
- Non-Accrual Status: Two loans are currently on non-accrual status. Cumulative interest of $5.2 million related to these loans was not recorded in interest income.
- Regulatory Compliance: The company must maintain its RIC status by distributing at least 90% of its investment company taxable income. Failure to do so would subject the company to corporate income tax.
Key Facts for Investor Verification
- Verify the impact of the BC Partners acquisition on future investment strategy and fee structures under the new advisory agreement.
- Monitor the performance and potential recovery of the two loans currently on non-accrual status (Mingle Healthcare Solutions and JobGet Holdings).
- Assess the sustainability of the dividend yield given the decline in Net Investment Income and the reliance on unrealized gains to support total return.
- Review the company's ability to maintain its asset coverage ratio above the 150% threshold required by the 1940 Act, especially given the $558.3 million in outstanding debt.
- Confirm the status of the $176.7 million in unfunded commitments to portfolio companies and the Runway-Cadma I LLC joint venture.